F. Fabris

1.1k total citations
58 papers, 767 citations indexed

About

F. Fabris is a scholar working on Hematology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, F. Fabris has authored 58 papers receiving a total of 767 indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Hematology, 20 papers in Genetics and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in F. Fabris's work include Platelet Disorders and Treatments (29 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (15 papers) and Blood properties and coagulation (12 papers). F. Fabris is often cited by papers focused on Platelet Disorders and Treatments (29 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (15 papers) and Blood properties and coagulation (12 papers). F. Fabris collaborates with scholars based in Italy, United States and Belarus. F. Fabris's co-authors include Antonio Girolami, Maria Luigia Randi, A Girolami, Alessandra Casonato, Guido Luzzatto, Marco Boscaro, Bruno Girolami, Roberto Sartori, Luigi De Marco and Elisabetta Ruzzon and has published in prestigious journals such as Journal of Clinical Investigation, Blood and Journal of Periodontology.

In The Last Decade

F. Fabris

54 papers receiving 741 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Fabris Italy 16 490 178 161 117 104 58 767
Guido Luzzatto Italy 14 453 0.9× 114 0.6× 255 1.6× 204 1.7× 94 0.9× 47 797
H. Ireland United Kingdom 21 677 1.4× 166 0.9× 125 0.8× 253 2.2× 162 1.6× 47 987
Sune Isacson Sweden 13 371 0.8× 93 0.5× 180 1.1× 180 1.5× 191 1.8× 30 853
G Mellbring Sweden 14 328 0.7× 55 0.3× 155 1.0× 152 1.3× 266 2.6× 25 786
Kouzou Minamikawa Japan 14 339 0.7× 75 0.4× 147 0.9× 143 1.2× 113 1.1× 24 606
I. Yudelman United States 7 303 0.6× 81 0.5× 86 0.5× 110 0.9× 300 2.9× 12 662
Mario von Depka Germany 18 680 1.4× 156 0.9× 164 1.0× 116 1.0× 78 0.8× 44 948
Shogo Takano Japan 6 387 0.8× 70 0.4× 83 0.5× 268 2.3× 113 1.1× 13 703
Joost C. M. Meijers Netherlands 9 359 0.7× 38 0.2× 135 0.8× 166 1.4× 287 2.8× 9 826
Wataru Tatewaki Japan 14 369 0.8× 108 0.6× 46 0.3× 90 0.8× 125 1.2× 41 543

Countries citing papers authored by F. Fabris

Since Specialization
Citations

This map shows the geographic impact of F. Fabris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Fabris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Fabris more than expected).

Fields of papers citing papers by F. Fabris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Fabris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Fabris. The network helps show where F. Fabris may publish in the future.

Co-authorship network of co-authors of F. Fabris

This figure shows the co-authorship network connecting the top 25 collaborators of F. Fabris. A scholar is included among the top collaborators of F. Fabris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Fabris. F. Fabris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Foresta, Carlo, Giacomo Strapazzon, Luca De Toni, et al.. (2012). Platelets express and release osteocalcin and co‐localize in human calcified atherosclerotic plaques. Journal of Thrombosis and Haemostasis. 11(2). 357–365. 27 indexed citations
2.
Castelli, Roberto, Elena Cassinerio, Maria Domenica Cappellini, et al.. (2007). Heparin Induced Thrombocytopenia: Pathogenetic, Clinical, Diagnostic and Therapeutic Aspects. Cardiovascular & Haematological Disorders - Drug Targets. 7(3). 153–162. 19 indexed citations
3.
Paternoster, D.M., et al.. (2006). The management of feto-maternal alloimmune thrombocytopenia: Report of three cases. The Journal of Maternal-Fetal & Neonatal Medicine. 19(8). 517–520. 3 indexed citations
4.
Girolami, Antonio, et al.. (2004). Pregnancies and Oral Contraceptive Therapy in Severe (Homozygons) FXII Deficiency: A Study in 12 Patients and Review of the Literature. Journal of Thrombosis and Thrombolysis. 18(3). 209–212. 7 indexed citations
5.
Fabris, F., et al.. (2002). Risk factors for thrombosis in patients with immune mediated heparin‐induced thrombocytopenia. Journal of Internal Medicine. 252(2). 149–154. 50 indexed citations
6.
Fabris, F., et al.. (2000). Clinical and laboratory factors that affect the post-transfusion platelet increment. Transfusion Science. 23(1). 63–68. 20 indexed citations
7.
Fabris, F., et al.. (2000). Indirect study of thrombopoiesis(TPO, reticulated platelets, glycocalicin)in patients with hereditary macrothrombocytopenia. European Journal Of Haematology. 64(3). 151–156. 18 indexed citations
8.
Steffan, Agostino, et al.. (1998). Glycocalicin in the diagnosis and management of immune thrombocytopenia. European Journal Of Haematology. 61(2). 77–83. 9 indexed citations
9.
Fabris, F., et al.. (1997). Chronic isolated macrothrombocytopenia with autosomal dominant transmission: a morphological and qualitative platelet disorder. European Journal Of Haematology. 58(1). 40–45. 7 indexed citations
10.
Randi, Maria Luigia, et al.. (1996). Antiplatelet glycoprotein autoantibodies in patients with autoimmune diseases with and without thrombocytopenia. Journal of Clinical Immunology. 16(6). 340–347. 10 indexed citations
11.
Steffan, Agostino, et al.. (1994). Detection of platelet-reactive antibodies by a new ELISA method based on the interaction of biotinylated platelets antigens with streptavidin-coated microtiter plates. Pathologie Biologie. 42(8). 805–806. 1 indexed citations
13.
Marco, Luigi De, M. Mazzucato, F. Fabris, et al.. (1990). Variant Bernard-Soulier syndrome type bolzano. A congenital bleeding disorder due to a structural and functional abnormality of the platelet glycoprotein Ib-IX complex.. Journal of Clinical Investigation. 86(1). 25–31. 44 indexed citations
14.
Randi, Maria Luigia, et al.. (1990). Multiple, relapsing thrombosis in a young man with primary thrombocytosis. Blood Coagulation & Fibrinolysis. 1(3). 331–332. 7 indexed citations
15.
Fabris, F., et al.. (1990). Thrombocytosis in young people: Evaluation of 57 cases diagnosed before the age of 40. Annals of Hematology. 60(4). 233–237. 24 indexed citations
16.
Randi, Maria Luigia, Alessandra Casonato, F. Fabris, Carlos P. Vío, & Antonio Girolami. (1987). The Significance of Thrombocytosis in Old Age. Acta Haematologica. 78(1). 41–44. 9 indexed citations
17.
Casonato, Alessandra, F. Fabris, Marco Boscaro, & Antonio Girolami. (1987). Increased factor VIII/vWf levels in patients with reduced platelet number. Annals of Hematology. 54(5). 281–288. 11 indexed citations
18.
Fabris, F., et al.. (1985). The effect of different doses of 32P in the treatment of primary thrombocytosis.. PubMed. 112(6). 950–6. 1 indexed citations
19.
Fabris, F., Alessandra Casonato, L. Visentin, et al.. (1983). Normal and low molecular weight heparins: interaction with human platelets. European Journal of Clinical Investigation. 13(2). 135–139. 23 indexed citations
20.
Fabris, F., Maria Luigia Randi, Rodolfo Sbrojavacca, Alessandra Casonato, & Antonio Girolami. (1981). The possible value of platelet aggregation studies in patients with increased platelet number. Annals of Hematology. 43(5). 279–285. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026